Allele Biotechnology and Pharmaceuticals Files Two Lawsuits for Patent Infringement for the Unauthorized Use of mNeonGreen in Development and Testing of COVID Vaccines and Therapeutics

SAN DIEGO–(BUSINESS WIRE)–Allele Biotechnology and Pharmaceuticals, Inc. (“Allele”), a San Diego-based company focused on developing and adapting cutting edge technology for clinical and therapeutic use, filed two patent infringement lawsuits today – one in New York against Regeneron Pharmaceuticals and the other in California against Pfizer and BioNTech. Both complaints address the infringement of Allele’s patented mNeonGreen technology, an important reagent used in the development of therap

Source